Press Releases
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results
Endo Announces Peyronie's Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association
Endo Announces Divestiture of International Pharmaceuticals Business
Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call
Endo Presents Healthcare Provider Survey at Joint Meeting of International Society for the Study of Women's Sexual Health (ISSWSH) and International Society for Sexual Medicine (ISSM)
Endo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
Endo Launches "Steve's Journey," the First Branded Dupuytren's Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum)
Endo Launches New Peyronie's Disease Campaign: I Got Somebody
Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine nasal solution, USP) Due to the Potential for Administration Errors